Device / Technology News

RSS

Cedars-Sinai develops AI tool for faster and cheaper tumor analysis

A team led by Cedars-Sinai Health Sciences University investigators has created a faster, cheaper way to determine the genes expressed in cancerous tumors.

12 May 2026

KIT researchers develop contact-free laser technique to rotate microscopic samples

Until now, it has been technically nearly impossible to rotate highly sensitive samples in all directions under a microscope without making contact.

12 May 2026

Johns Hopkins researchers develop life-saving AI for early sepsis detection

An early warning system for sepsis, one of the deadliest infections for hospital patients, has been approved for use by the FDA, one of the first AI-based medical tools to get clearance.

12 May 2026

Using AI to improve success rates of fecal microbiota transplants

MOZAIC leverages deep learning to optimize fecal microbiota transplantation, enhancing treatment efficacy through precise donor-recipient microbiome matching.

12 May 2026

INDIGO Biosciences expands reporter assay capabilities with new Transrepression Assay Services

INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities for drug discovery teams studying pathway cross-talk, selective modulation, and transcription factor-mediated gene suppression.

From INDIGO Biosciences, Inc. 11 May 2026

Scientists call for explainable AI in protein language models

Protein language models are artificial intelligence tools which help engineer proteins with useful properties, including completely new structures never seen before in nature.

11 May 2026

New AI chip identifies meibomian gland dysfunction within milliseconds

A research team from Peking Union Medical College Hospital and Tsinghua University has developed a compact optical AI chip that can identify meibomian gland dysfunction (MGD)-a major cause of dry eye disease-with more than 96% accuracy by analyzing the tissue's spectral signatures.

11 May 2026

New AI framework predicts how cells make fate decisions

Scientists at the Stowers Institute for Medical Research, Helmholtz Munich, the Technical University of Munich, and the University of Oxford have developed RegVelo - a new AI framework that simultaneously models cellular dynamics and gene regulation, enabling researchers to predict, simulate, and experimentally validate how cells make fate decisions.

11 May 2026

Psychological frameworks help AI models to provide better health care advice

Researchers at Technische Universität Berlin have discovered that teaching Large Language Models (LLMs) to mimic human intuition and reasoning significantly improves their ability to provide accurate medical care-seeking advice.

11 May 2026

Brain controlled hearing technology helps people isolate voices in crowds

Scientists at Columbia University's Zuckerman Institute have the first direct evidence from human studies that brain-controlled hearing technology can help people single out a voice in a crowd.

11 May 2026

New photoacoustic imaging helps robotic surgeons avoid hidden anatomical hazards

Surgery is a complicated endeavor. Even a successful surgery can lead to complications, and even the best surgeons sometimes have unsuccessful surgeries.

11 May 2026

New CRISPR RNA scissors specifically target and destroy hepatitis E virus

An enzymatic scissors recognizes and cuts viral RNA, but leaves the host cell unharmed. This opens up new antiviral strategies against hepatitis E.

11 May 2026

Shaping the future of asthma management with the NObreath® at ATS 2026

World leaders in breath analysis Bedfont® Scientific Ltd. are pleased to be attending this years American Thoracic Society (ATS) International Conference, to exhibit the innovative NObreath® Fractional exhaled Nitric Oxide (FeNO) device at booth 1236 alongside its US distributor coVita™.

From Bedfont® Scientific Ltd 11 May 2026

Hovione and IDC Intranasal Drug Delivery Platform available for commercial partnerships

Hovione, a global integrated specialist CDMO, and Industrial Design Consultancy Ltd (IDC), an international product development company, today announced that their Intranasal Drug Delivery Platform has reached a new milestone, with its lead single-use nasal dry powder device now available for commercial partnerships.

From Hovione 11 May 2026

Uncountable expands specialty chemicals footprint with four new deals

Uncountable, a software company that develops AI platforms for end-to-end product development, today announced it has signed four new agreements with specialty chemicals organizations to support formulation development, scale-up, and production optimization.

From Uncountable Inc. 11 May 2026

Nuclera launches antibody triage service to advance AI-driven antibody discovery

Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its antibody screening service to streamline the transition from antibody hit generation to lead selection.

From Nuclera 11 May 2026

Study reveals immune differences between titanium and zirconia implants

Zirconia is widely regarded as a promising alternative to titanium for bone and dental implants because of its aesthetic advantages, biocompatibility, and potential to reduce metal ion release.

10 May 2026

Copper-based nanoplatform shows promise against metastatic tumor growth

What happens if cancer cells lose both their mitochondrial energy supply and their glycolytic backup system? This question is central to a new study published in Research by researchers from Northwestern Polytechnical University and collaborating institutions.

10 May 2026

Non-invasive swab test offers fast, accurate tuberculosis detection worldwide

A portable molecular test, MiniDock MTB, detected pulmonary tuberculosis rapidly and accurately across seven high-burden countries, using sputum or tongue swab samples. The study suggests the low-cost, battery-operated platform could expand near-point-of-care TB diagnosis in low-resource settings, although real-world implementation and drug-resistance integration still need evaluation.

10 May 2026

Advanced 3D heart models could transform cardiovascular drug discovery

Cardiovascular disease remains a leading global health burden, yet many preclinical systems still struggle to predict how candidate drugs will perform in the human heart.

10 May 2026